Literature DB >> 12886138

Epidermal nevus syndrome: megalencephaly with bihemispheric and cerebellar involvement: imaging and neuropathologic correlation.

Ahmed N Abdelhalim1, Toshio Moritani, Eric Richfield, Sven E Ekholm, Per-Lennart Westesson.   

Abstract

Epidermal nevus syndrome (ENS) is a sporadic neurocutaneous disorder characterized by the combination of epidermal nevi with significant central nervous system, eye, and skeletal abnormalities. Hemimegalencephaly and related brain abnormalities are the dominant neuropathologic abnormalities in ENS. Magnetic resonance imaging features of the case reported here revealed enlargement of both cerebral hemispheres and malformed basal ganglia, with incomplete separation of the caudate nucleus and putamen. In addition, the right cerebellar hemisphere was enlarged, with disorganized folia. None of these findings have been reported previously in this disorder.

Entities:  

Mesh:

Year:  2003        PMID: 12886138     DOI: 10.1097/00004728-200307000-00014

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  4 in total

Review 1.  Hemimegalencephaly: clinical implications and surgical treatment.

Authors:  C Di Rocco; D Battaglia; D Pietrini; M Piastra; L Massimi
Journal:  Childs Nerv Syst       Date:  2006-07-05       Impact factor: 1.475

2.  Epilepsy surgery in epidermal nevus syndrome variant with hemimegalencephaly and intractable seizures.

Authors:  T Loddenkemper; A V Alexopoulos; P Kotagal; A Moosa; D K Lachhwani; A Gupta; W Bingaman; E Wyllie
Journal:  J Neurol       Date:  2008-11-13       Impact factor: 4.849

Review 3.  Diffusion tensor imaging and fiber tractography in brain malformations.

Authors:  Andrea Poretti; Avner Meoded; Andrea Rossi; Charles Raybaud; Thierry A G M Huisman
Journal:  Pediatr Radiol       Date:  2013-01-04

4.  Epidermal nevus syndrome with internal carotid artery occlusion and intracranial and orbital lipomas.

Authors:  M Canyigit; K K Oguz
Journal:  AJNR Am J Neuroradiol       Date:  2006-08       Impact factor: 3.825

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.